Ihe na-arụ ọrụ:
Histrelin Acetate bụ agonist LHRH (GnRH) nwere ike. Mgbe mmụba na-adịru nwa oge, nchịkwa na-aga n'ihu nke histrelin na-ebute mbelata nke ọkwa LH na FSH site na nkwụsị nke ovarian na testicular steroid biosynthesis.
Usoro ihe omimi:
C66H86N18O12
Mass Molecular emetụtara:
1323.52 g/mol
CAS-Ọnụ ọgụgụ:
76712-82-8 (ụgbụ), 220810-26-4 (acetate)
Nchekwa ogologo oge:
-20 ± 5°C
Ntụpọ:
(Des-Gly10,D-His(Bzl)6,Pro-NHEt9)-LHRH
Usoro:
Pyr-His-Trp-Ser-Tyr-D-His (Bzl) -Leu-Arg-Pro-NHEt acetate nnu.
Mpaghara Ngwa:
Central precocious puberty
Nkọwapụta Ụlọ ọrụ:
aha ụlọ ọrụ: Shenzhen JYMed Technology Co., Ltd.
Afọ tọrọ ntọala: 2009
Isi obodo: nde 89.5 RMB
Isi ngwaahịa: Oxytocin Acetate, Vasopressin Acetate, Desmopressin Acetate, Terlipressin acetate, Caspofungin acetate, Micafungin sodium, Eptifibatide acetate, Bivalirudin TFA, Deslorelin Acetate, Glucagon Acetate,Histrelin acetate,Liraglutide Acetate,Linaclotide Aceteate,Degarelix Acetate,Buserelin Acetate,Cetrorelix Acetate,Goserelin Acetate, Argireline Acetate, Metrixyl Acetate, Snap-8, ....
Anyị na-agbalịsi ike ịnọgide na innovations ọhụrụ peptide njikọ technology na usoro njikarịcha, na anyị ọrụ otu nwere ihe karịrị afọ iri nke ahụmahụ peptide synthesis.JYM ka ọma osụk a otutu
nke ANDA peptide APIs na ngwaahịa CFDA emebere ma nwee ihe karịrị patent iri anọ akwadoro.
Osisi peptide anyị dị na Nanjing, mpaghara Jiangsu ma guzobe ụlọ ọrụ nke 30,000 square mita na nrube isi na ụkpụrụ cGMP. Ma ndị ahịa ụlọ na ndị mba ofesi enyochala ma nyochaa ụlọ ọrụ mmepụta ihe.
Na ya magburu onwe àgwà, kasị asọmpi price na ike oru nkwado, JYM bụghị nanị nwetara recognitions maka ngwaahịa ya si Research òtù na-emepụta ọgwụ industries, ma na-aghọ otu n'ime ndị kasị pụrụ ịdabere na suppliers nke peptides na China,. JYM raara onwe ya nye ịbụ otu n'ime ndị na-eweta peptide na-eduga n'ụwa n'ọdịnihu dị nso.